L-Arginine and Sickle Cell Disease

Clinical trial NCT01142219 · COMPLETED

Trial details

NCT number: NCT01142219
Sponsor: Hospital de Clinicas de Porto Alegre
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2006-09-01
Primary completion: 2008-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.